Cyprus facial-neuromusculoskeletal syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2674OMIM:123853Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cyprus facial-neuromusculoskeletal syndrome is a very rare inherited condition that was first described in families from Cyprus, an island in the eastern Mediterranean. The syndrome affects several parts of the body at the same time, including the face, nervous system, muscles, and skeleton. Because it touches so many body systems, doctors call it a 'neuromusculoskeletal' syndrome, meaning it involves the nerves, muscles, and bones together. People with this condition typically have distinctive facial features that can be noticed at birth or in early childhood. These may include unusual spacing or shape of the eyes, a broad or flat nose, and other subtle differences in the structure of the face. Along with these facial features, affected individuals often experience muscle weakness, problems with movement and coordination, and changes in the bones or joints that can affect how they walk or use their hands. Because this syndrome is extremely rare and has only been reported in a very small number of families, medical knowledge about it is still limited. There is currently no cure, and treatment focuses on managing individual symptoms. A team of specialists — including neurologists, orthopedic doctors, and geneticists — typically works together to support affected individuals and their families. Early diagnosis and therapy can help improve quality of life and daily functioning.

Key symptoms:

Distinctive facial features present from birthMuscle weakness affecting movementProblems with coordination and balanceBone or joint abnormalitiesDelayed motor milestones such as sitting or walkingIntellectual disability or learning difficulties in some casesUnusual facial structure including eye spacing differencesSkeletal abnormalities affecting posture or limb shapeReduced muscle tone (floppiness) in infancy

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Cyprus facial-neuromusculoskeletal syndrome.

View clinical trials →

No actively recruiting trials found for Cyprus facial-neuromusculoskeletal syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cyprus facial-neuromusculoskeletal syndrome community →

No specialists are currently listed for Cyprus facial-neuromusculoskeletal syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cyprus facial-neuromusculoskeletal syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cyprus facial-neuromusculoskeletal syndromeForum →

No community posts yet. Be the first to share your experience with Cyprus facial-neuromusculoskeletal syndrome.

Start the conversation →

Latest news about Cyprus facial-neuromusculoskeletal syndrome

No recent news articles for Cyprus facial-neuromusculoskeletal syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What genetic tests should we do to confirm the diagnosis and identify the gene involved?,Which therapies — physical, occupational, or speech — would benefit my child most right now?,Are there any clinical trials or research studies we could participate in?,What signs should prompt us to seek urgent medical attention?,How will this condition change over time, and what should we watch for as my child grows?,Are other family members at risk, and should they be tested?,Are there any patient registries or specialist centers that focus on this condition?

Common questions about Cyprus facial-neuromusculoskeletal syndrome

What is Cyprus facial-neuromusculoskeletal syndrome?

Cyprus facial-neuromusculoskeletal syndrome is a very rare inherited condition that was first described in families from Cyprus, an island in the eastern Mediterranean. The syndrome affects several parts of the body at the same time, including the face, nervous system, muscles, and skeleton. Because it touches so many body systems, doctors call it a 'neuromusculoskeletal' syndrome, meaning it involves the nerves, muscles, and bones together. People with this condition typically have distinctive facial features that can be noticed at birth or in early childhood. These may include unusual spaci

How is Cyprus facial-neuromusculoskeletal syndrome inherited?

Cyprus facial-neuromusculoskeletal syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Cyprus facial-neuromusculoskeletal syndrome typically begin?

Typical onset of Cyprus facial-neuromusculoskeletal syndrome is neonatal. Age of onset can vary across affected individuals.